InflaRx (IFRX) Shareholder's Equity (2016 - 2026)
InflaRx (IFRX) Shareholder's Equity (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
502.95 Mn |
| 10 |
InflaRx |
764.68 Mn |
764.68 Mn |
10,877.40 |
43.19 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
43.19 Mn |
| Dec 31, 2025 |
48.37 Mn |
| Sep 30, 2025 |
53.04 Mn |
| Jun 30, 2025 |
64.57 Mn |
| Mar 31, 2025 |
74.12 Mn |
| Dec 31, 2024 |
65.63 Mn |
| Sep 30, 2024 |
71.69 Mn |
| Jun 30, 2024 |
88.47 Mn |
| Mar 31, 2024 |
102.94 Mn |
| Dec 31, 2023 |
110.37 Mn |
| Sep 30, 2023 |
128.44 Mn |
| Jun 30, 2023 |
135.73 Mn |
| Mar 31, 2023 |
84.34 Mn |
| Dec 31, 2022 |
90.14 Mn |
| Sep 30, 2022 |
100.26 Mn |
| Jun 30, 2022 |
108.98 Mn |
| Mar 31, 2022 |
106.76 Mn |
| Dec 31, 2021 |
120.44 Mn |
| Sep 30, 2021 |
135.89 Mn |
| Jun 30, 2021 |
148.86 Mn |
